Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
229239 (2007)
DOI: 10.1556/AVet.55.2007.2.9
*
Corresponding author: Sndor Gyrgy Fekete; E-mail: Fekete.Sandor@aotk.szie.hu,
dietvet@yahoo.com; Fax: 0036 (1) 478-4128
Basic notions
gested. These mechanisms are also involved in the control of both carbohydrate
and lipid metabolism, cell differentiation and growth and cytokine, adhesion
molecule and eicosanoid production.
The differentiation of adipocytes is a transcriptional regulatory cascade,
involving the member of the CCAAT-enhancer binding protein (C/EBP) family,
SREBPs and the adipocyte determination and differentiation dependent factor 1,
which enhance the expression of PPAR. The latter induces exit from the cell
cycle and stimulates the production of adipocyte specific genes. The synchro-
nised functioning of this cascade is supported by the hormonal events of the or-
ganism (Brun et al., 1996). Normal adipocytes protect lean tissue from the lipo-
toxic effects of excess or oxidised lipids. The high-fat diet-induced adipocyte
hypertrophy and insulin resistance is mediated by PPAR (Kubota et al., 1999).
In fact, the development of insulin resistance during obesity (the type II diabetes)
can also be considered as a protective mechanism reducing glucose-derived lipo-
genesis in cells (Ungar, 2003).
sponsive to the peroxisome proliferators have been found in the promoter regions
of several genes encoding proteins that are involved in lipid metabolism. Activa-
tion of PPAR by free fatty acids, eicosanoids or xenobiotics help to bind PPAR
to specific areas of target genes, leading to activation or repression of gene ex-
pression. Interestingly enough, dietary fat does not suppress body lipid mobilisa-
tion in fresh lactating dairy cows (Komaragiri et al., 1998).
It is clearly demonstrated that dietary carbohydrates, both independently
and through insulin effect, deeply influence the transcription of the fatty acid
synthase gene in a number of species. In rodents, immobilisation stress, starva-
tion, diabetes and chemical compounds (e.g. clofibrate) may also stimulate the
expression of PPAR and peroxisomal -oxidation of fatty acids (Singh, 1997).
Ingestion of high-fat diets downregulates insulin-responsive glucose transporter
(GLUT4) protein expression in adipose tissue, thereby increasing leptin gene ex-
pression (Houseknecht et al., 1998). In horses, the expression of muscle GLUT-4
depends not only on the dietary carbohydrate source (sugar or starch), but also on
physical activity.
Dietary essential fatty acids are the precursors of eicosanoids. Among the
eicosanoids derived from arachidonic acid, prostaglandin E2 is known to possess
immunosuppressive actions. Thus, it has been a prevailing hypothesis that the
immunomodulatory roles of dietary fatty acids are mediated, at least partly,
through the alteration of prostaglandin biosynthesis. Summarising, it becomes
clear now that multiple steps in various receptor-mediated signalling pathways
can be modulated by dietary fatty acids. In turn, PPAR expression is nutrition-
ally regulated by high-fat diet, fasting and linoleic acid.
CLAs are potent activators of PPARs and, in turn, this function is thought
to be related to the anticarcinogenic effect of certain CLAs. Moreover, CLAs in-
duce apoptosis in adipocytes. The anti-inflammatory effect of some CLAs can be
explained by the inhibition of proinflammatory cytokine mRNA expression, in-
cluding interleukin-6 (IL-6), tumour necrosis factor (TNF) and, on the con-
trary, by the induction of gene expression of PPAR both in vivo (in weaned pig-
lets challenged with lipopolysaccharide) and in blood mononuclear cell culture
(Changhua et al., 2005).
Milk is one of the richest natural sources of CLAs. The ruminant milk fat
derives from two sources: approximately half of it comes from the uptake of
blood fatty acids, whilst the remaining part is formed by the de novo fatty acid
synthesis in the mammary gland. Composition and function of the rumen micro-
flora have great influence on the pattern of fatty acids available to the mammary
gland. Under normal conditions, the linoleic acid (cis-9, cis-12 C18:2) first be-
comes conjugated linoleic acid, CLA (cis-9, trans-11 CLA or rumenic acid),
which in turn transforms into vaccenic acid (trans-11 C18:1) and finally into
stearic acid (C18:0). There is also a reverse pathway from vaccenic acid under
the influence of 9-desaturase enzyme activity in the liver, adipose tissue and
mammary gland to form rumenic acid (Griinari et al., 2000). The same metabolic
pathway has been demonstrated both in lactating women and in dairy cows
(Mosley et al., 2006a, b). Of the latter, cis-9, trans-11 CLA gives more than two-
thirds of the CLAs in milk-fat and it is also present in beef meat.
Under certain circumstances (for example, with ingestion of diets low in
effective fibre), the rumen environment and bacterial population differ from the
average. Altered microflora will produce CLAs other than rumenic acid; the con-
centration of trans-10, cis-12 CLA may increase. The latter is an efficient inhibi-
tor of milk fat synthesis in the mammary gland and is part of the biohydrogena-
tion theory of milk fat depression (Bauman et al., 2006). The trans-10, cis-12
C18:2 has been shown to decrease mRNA expression for acetyl-CoA carboxy-
lase, fatty acid synthase, 9 desaturase, lipoprotein lipase, fatty acid binding pro-
tein, glycerol phosphate acyltransferase and acylglycerol phosphate acyltrans-
ferase (Baumgard et al., 2002). The biohydrogenation hypothesis has been con-
firmed both in cows and sheep and in lactating mice (Lin et al., 2004), by apply-
ing the above-mentioned CLA isomer. Kim et al. (2001) isolated from rumen
content a bacterium (Megasphaera elsdenii) capable of synthesising trans-10,
cis-12 CLA, while Mosley et al. (2002) demonstrated the biohydrogenating abil-
ity of mixed rumen microbes in vitro. This means that a natural bacterial product
in low amounts is capable of influencing mammary gene expression and thereby
controlling milk fat production. The dose-response relation is curvilinear (Lock
et al., 2007).
Vitamin A exerts its regulatory function in the form of retinol and retinoic
acid. The most important target tissues are in the adrenal glands, testes, cerebel-
lum, kidneys, prostate, cerebral cortex, skin and the viscera. After retinoic acid
binds to its receptor, it will stimulate the transcription and translation of vitamin
A-responsive genes, including some involved in cell differentiation (growth
hormone, glycerolphosphate dehydrogenase and leptin production among oth-
Cis-9, trans-11 CLA or rumenic acid, present in milk fat and beef meat,
has been found to have anticarcinogenic effect in rats, where it was found to be
capable of reducing the incidence of mammary cancer (Aimutis, 2004). Overex-
pression of cyclo-oxygenase-2 (COX-2) is thought to be one of the causative fac-
tors of breast tumour genesis. By repressing the activation of COX-2 transcrip-
tion, mixtures of CLA isomers were able to counterbalance carcinogenic in-
flammation in cell culture (Degner et al., 2006). In the case of colon cancer cells
exclusively the trans-10, cis-12 CLA was capable of inhibiting cell cycle pro-
gression via induction of a cyclin-dependent kinase inhibitor, the p21 (Cho et al.,
2006).
Some of these compounds (the type of effective molecule depends on the
disease, but mostly the cis-9, trans-11 CLA) have also proved to have antia-
therogenic, antiobesity and antidiabetic characteristics both against type I and
type II diabetes. To prevent obesity and type II diabetes, the direct modulation of
gene expression by nutrients is also a potential mechanism (Patti and Kahn,
2004). The influence of diet on the phenotypic manifestation in some cases is
drastically determinant. The prenatal (maternal) nutrient supply may influence
not only the development of adipose tissue, but also the colour of the offspring
mouse pups (Waterland and Garza, 1999; Waterland and Jirtle, 2004). The inci-
dence of this so-called metabolic imprinting significantly depends upon the
type of placenta, too.
Promoting research: Nutrigenomics holds great promise for discoveries in
veterinary and human medicine, including profiles and characteristics of dietary
and body protein metabolism, development of food allergy, absorption and me-
tabolism of nutrients, their functions in uterine development, growth, reproduc-
tion and health, finding biomarkers of nutritional status and diseases (Kussmann
et al., 2006) and even assisting in target-designed drug development (Swanson et
al., 2003).
In human fields of study, there are already preliminary results from apply-
ing synthetic compounds to influence peroxisome proliferator-activated receptors
and/or liver X receptors (LXR) in order to cure dyslipidaemia, diabetes, obesity
and atherosclerosis (Barish, 2006). Nevertheless, it should be borne in mind that
these treatments involve delicately balanced sophisticated pathways, therefore
the expected result may be accompanied by undesirable side effects. For exam-
ple, even though fat accumulation can be prevented using trans-10, cis-12 CLA,
via the modulation of PPAR receptor, glucose homeostasis can also be altered.
Moreover, in the veterinary field, nutrigenomical databanks make possible
the selection for metabolic disease resistance. Hopefully, in the near future,
nutrigenomics may provide us with clearly determined, cell-physiologically ap-
propriate nutrient allowances for production animals. Data will enable us to
screen susceptible breeds or individuals and to give guidance for optimised or
individualised diets to prevent the onset of polygenic, nutrition-related disor-
Acknowledgements
This review of the literature could not have been prepared without the financial
support of the HAESF/CIEES and the kind, open and friendly help of all the co-workers
of the Department of Animal Science, Cornell University, Ithaca, NY.
References
Aimutis, W. R. (2004): Bioactive properties of milk proteins with particular focus on anticarcino-
genesis. J. Nutr. 134, 98989958.
Arai, K., Soga, T., Ohata, H., Otagiri, A. and Shibasali, T. (2004): Effect of food restriction on
peroxisome proliferator-activated receptor- and glucocorticoid receptor signalling in adi-
pose tissue of normal rats. Metabolism 53, 2836.
Barish, G. D. (2006): Peroxisome proliferator-activated receptors and liver X receptors in athero-
sclerosis and immunity. J. Nutr. 136, 690694.
Bauman, D. E., Mather, I. H., Wall, R. J. and Lock, A. L. (2006): Major advances associated with
the biosynthesis of milk. J. Dairy Sci. 89, 12351243.
Baumgard, L. H., Matilashvili, E., Carl, B. A., Dwyer, D. A. and Bauman, D. E. (2002): Trans-10,
cis-12 CLA decreases lipogenic rates and expression of genes involved in milk lipid syn-
thesis in dairy cows. J. Dairy Sci. 85, 21552163.
Bohnsack, B. L. and Hirschi, K. K. (2004): Nutrient regulation of cell cycle progression. Ann. Rev.
Nutr. 24, 433453.
Bremner, I. and Beattie, J. H. (1990): Metallothionein and the trace minerals. Annu. Rev. Nutr. 10,
6383.
Brun, R. P., Kim, J. B., Hu, E., Altiok, S. and Spiegelman, B. M. (1996): Adipocyte differentiation:
a transcriptional regulatory cascade. Curr. Opin. Cell Biol. 8, 826832.
Changhua, L., Jindong, Y., Defa, L., Lidan, Zh., Shiyan, Q. and Jianjun, X. (2005): Conjugated li-
noleic acid attenuates the production and gene expression of proinflammatory cytokines in
weaned pigs challenged with lipopolysaccharide. J. Nutr. 135, 239244.
Cho, H. J., Kim, E. J., Lim, S. S., Kim, M. K., Sung, M-K., Kim, J-S. and Park, J. H. Y. (2006):
Trans-10, cis-12, not cis-9, trans-11, conjugated linoleic acid inhibits G1-S progression in
HT-29 human colon cancer cells. J. Nutr. 136, 893898.
Clarke, S. D. (1993): Regulation of fatty acids synthase gene expression: an approach for reducing
fat accumulation. J. Anim. Sci. 71, 19571965.
Clarke, S. D. and Abraham, S. (1992): Gene expression: nutrient control of pre- and post-
transcriptional events. FASEB J. 6, 31463152.
De, S. K., Enders, G. C. and Andrews, G. K. (1991): Metallothionein mRNA stability in chicken
and mouse cells. Biochim. Biophys. Acta 1090, 223229.
Degner, S. C., Kemp, M. Q., Bowden, G. T. and Romagnolo, D. F. (2006): Conjugated linoleic
acid attenuates cyclooxygenase-2 transcriptional activity via an anti-AP-1 mechanism in
MCF-7 breast cancer cells. J. Nutr. 136, 421427.
Desvergne, B., Ijpenberg, A., Devchand, P. R. and Wahli, W. (1998): The peroxisome proliferator-
activated receptors at the crossroad of diet and hormonal signalling. J. Steroid Biochem.
Mol. Biol. 65, 6574.
Drackley, J. K. (1999): Biology of dairy cows during the transition period: the final frontier? J.
Dairy Sci. 82, 22592273.
Dugan, M. E. R., Aalhus, J. L., Schaefer, A. L. and Kramer, J. K. G. (1997): The effect of conju-
gated linoleic acid on fat to lean repartitioning and feed conversion in pigs. Can. J. Anim.
Sci. 77, 723725.
Falus, A. (2003): Histamine, part of the metabolome. Acta Biol. Hung. 54, 2734.
Fong, L.Y., Zhang, L., Jiang, Y. and Farber, J. L. (2005): Dietary zinc modulation of COX-2 ex-
pression and lingual and esophageal carcinogenesis in rats. J. Natl Cancer Inst. 97, 4050.
Fukuda, H., Iritani, N., Sugimoto, T. and Ikeda, H. (1999): Transcriptional regulation of fatty acid
synthase gene by insulin/glucose, polyunsaturated fatty acids and leptin in hepatocytes and
adipocytes in normal and genetically obese rats. Eur. J. Biochem. 260, 505511.
Granlund, L., Pedersen, J. I. and Nebb, H. I. (2005): Impaired lipid accumulation by trans-10, cis-
12 CLA during adipocyte differentiation is dependent on timing and length of treatment.
Biochim. Biophys. Acta 1687, 1122.
Griinari, J. M., Cori, B. A., Lacy, S. H., Chouinard, P. Y., Nurmela, K. V. V. and Bauman, D. E.
(2000): Conjugated linoleic acid is synthesized endogenously in lactating dairy cow by 9-
desaturase. J. Nutr. 130, 22852291.
Herzog, A., Kindermann, B., Doering, F., Daniel, H. and Wenzel, U. (2004): Pleiotropic molecular
effects of the pro-apoptotic dietary constituent flavone in human colon cancer cells identi-
fied by protein and mRNA expression profiling. Proteomics 4, 24552464.
Houseknecht, K. L., Baile, C. A., Matteri, R. L. and Spurlock, M. E. (1998): The biology of leptin:
a review. J. Anim. Sci. 76, 14051420.
Hsu, Sh-Ch. and Huang, Ch-J. (2006): Reduced fat mass in rats fed high oleic acid-rich safflower
oil diet is associated with changes in expression of hepatic PPAR and adipose SREBP-1c-
regulated genes. J. Nutr. 136, 17791785.
Jump, D. B. (1999): Regulation of gene expression by dietary fat. Ann. Rev. Nutr. 19, 6369.
Kim, Y. J., Liu, R. H., Rychlik, J. L. and Russel, J. B. (2001): The enrichment of a ruminal bacte-
rium (Megasphaera elsdeni YJ-4) that produces the trans-10, cis-12 isomer of conjugated
linoleic acid (CLA). J. Appl. Microbiol. 92, 976982.
Komaragiri, M. V. S., Casper, D. P. and Erdman, R. A. (1998): Factors affecting body tissue mobi-
lization in early lactation dairy cows. 2. Effect of dietary fat on mobilization of body fat
and protein. J. Dairy Sci. 81, 169175.
Kubota, N., Terauchi, Y., Miki, H. et al. (1999): PPAR mediates high-fat diet-induced adipocyte
hypertrophy and insulin resistence. Mol. Cell 4, 597609.
Kussmann, M., Raymond, F. and Affolter, M. (2006): OMICS-driven biomarker discovery in nutri-
tion and health. J. Biotechnol. 124, 758787.
Leone, T. C., Weinheimer, C. J. and Kelly, D. P. (1999): A critical role for the peroxisome prolif-
erators-activated receptor alpha (PPARalpha) in the cellular fasting response. The PPAR-
alpha-null mouse: a model of fatty acid oxidation disorders. Proc. Natl Acad. Sci. USA 96,
74737478.
Li, X., Yin, J., Li, D., Chen, X., Zand, J. and Zhou, X. (2006): Dietary supplementation with zinc
oxide increases IGF-I and IGF-I receptor gene expression in the small intestine of weanling
piglets. J. Nutr. 136, 17861791.
Lin, X., Loor, J. J. and Herbein, J. H. (2004): Trans-10, cis-12-18:2 is a more potent inhibitor of de
novo fatty acid synthesis and desaturation than cis-9, trans-11-18:2 in the mammary gland
of lactating mice. J. Nutr. 134, 13621368.
Lock, A. L., Tyburczy, C., Dwyer, D. A., Harvatine, K. J., Destaillats, F., Mouloungui, Z., Candy,
L. and Bauman, D. E. (2007): Trans-10 octadecanoic acid does not reduce milk fat synthe-
sis in dairy cows. J. Nutr. 137, 7176.
Mariman, E. C. M. (2006): Review. Nutrigenomics and nutrigenetics: the omics revolution in nu-
tritional science. Biotechnol. Appl. Biochem. 44, 119128.
McNeel, R. L. and Mersmann, H. J. (2003): Effects of isomers of conjugated linoleic acid on por-
cine adipocyte growth and differentiation. J. Nutr. Biochem. 14, 266274.
Mosley, E. E., Powell, G. L., Riley, M. B. and Jenkins, T. C. (2002): Microbial biohydrogenation
of oleic acid to trans isomers in vitro. J. Lipid Res. 43, 290296.
Mosley, E. E., McGuire, M. K., Williams, J. E. and McGuire, M. A. (2006a): Cis-9, trans-11 con-
jugated linoleic acid is synthesized from vaccenic acid in lactating women. J. Nutr. 136,
22972301.
Mosley, E. E., Shafii, B., Moate, P. J. and McGuire, M. A. (2006b): Cis-9, trans-11 conjugated li-
noleic acid is synthesized directly from vaccenic acid in lactating dairy cattle. J. Nutr. 136,
570575.
Nicholson, J. K., Holmes, E. and Wilson, I. D. (2005): Gut microorganisms, mammalian metabo-
lism and personalized health care. Nat. Rev. Microbiol. 3, 431438.
Ouellette, A. J., Aviles, L., Burnweit, C. A., Frederick, D. and Malt, R. A. (1982): Metallothionein
mRNA induction in mouse small bowel by oral cadmium and zinc. Am. J. Physiol. 243,
G396G403.
Patti, M. E. and Kahn, B. B. (2004): Nutrient sensor links obesity with diabetes risk. Nat. Med. 10,
10491050.
Pianetti, S., Guo, S., Kavanagh, K. T. and Sonnenshein, G. E. (2002): Green tea polyphenol epigal-
locatechin-3 gallate inhibits Her-2/neu signaling, proliferation and transformed phenotype
of breast cancer cells. Cancer Res. 62, 652655.
Roche, H. M. (2006): Review. Nutrigenomics new approaches for human nutrition research. J.
Sci. Food Agric. 86, 11561163.
Rosen, E. D., Walkey, C. J., Puigserver, P. and Spiegelman, B. M. (2000): Transcriptional regula-
tion of adipogenesis. Genes Dev. 14, 12931317.
Schoonjans, K., Staels, B. and Auwerx, J. (1996): The peroxisome proliferators activated receptor
(PPARs) and their effects on lipid metabolism and adipocytes differentiation. Biochim.
Biophys. Acta 1302, 93109.
Scribner, K. B., Odom, D. P. and McGrane, M. M. (2005): Vitamin A status in mice affects the his-
tone code of phosphoenolpyruvate carboxykinase gene in liver. J. Nutr. 135, 27742779.
Selvaraj, R. K and Klasing, K. C. (2006): Lutein and eicosapentaenoic acid interact to modify
iNOS mRNA levels through the PPAR/RXR pathway in chickens and HD11 cell lines. J.
Nutr. 136, 16101616.
Singh, I. (1997): Biochemistry of peroxisomes in health and disease. Mol. Cell. Biochem. 167, 129.
Swanson, K. S., Schook, L. B. and Fahey, G. C. Jr. (2003): Nutritional genomics: implication for
companion animals. J. Nutr. 133, 30333040.
Tsai, C-W., Yang, J-J., Chen, H-W., Sheen, L-Y. and Lii, C-K. (2005): Garlic organosulfur com-
pounds upregulate the expression of the class of glutathione S-transferase in rat primary
hepatocytes. J. Nutr. 135, 25602565.
Ungar, R. H. (2003): Lipid overload and overflow. Metabolic trauma and the metabolic syndrome.
Trends Endocrin. Metab. 14, 398403.
Waterland, R. A. and Garza, C. (1999): Potential mechanism of metabolic imprinting that lead to
chronic disease. Am. J. Clin. Nutr. 69, 179197.
Waterland, R. A. and Jirtle, R. L. (2004): Early nutrition, epigenic change at transposons and im-
printed genes, and enhanced susceptibility to adult chronic disease. Nutrition 20, 6368.
Yuichi, M., Sumio, K., Yochiaki, I., Kazuto, F., Igura, T. and Matsuzawa, Y. (1996): Biotin defi-
ciency decreases ornithine transcarbamylase activity and mRNA in rat liver. J. Nutr. 126,
6166.